Recalls by year
14
16
17
19
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 30, 2025DrugsFDA
Medisca Inc. recalls Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) dru
Hazard: CGMP Deviations
July 10, 2024DrugsFDA
Medisca Inc. recalls Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12
Hazard: CGMP Deviations and Presence of Particulate Matter: Glass
December 25, 2019DrugsFDA
Medisca, Inc. recalls Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901
Hazard: Failed Impurities/Degradation Specifications
September 27, 2017DrugsFDA
Medisca, Inc. recalls Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989
Hazard: CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
April 19, 2017DrugsFDA
Medisca, Inc. recalls ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by M
Hazard: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
April 19, 2017DrugsFDA
Medisca, Inc. recalls ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b) 1 g (NDC 38779-0869-06), c) 5 g (NDC 3877
Hazard: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
April 19, 2017DrugsFDA
Medisca, Inc. recalls ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d)
Hazard: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
April 19, 2017DrugsFDA
Medisca, Inc. recalls ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 grams (NDC 38779-0732-04) , c) 100 grams (NDC 3
Hazard: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
February 24, 2016DrugsFDA
Medisca Inc recalls CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use a
Hazard: Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.
May 7, 2014DrugsFDA
Medisca Inc. recalls Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compou
Hazard: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.